Viking Therapeutics to Report Financial Results for First Quarter 2017 After Market Close on May 10, 2017

http://ift.tt/1i7vvyN

SAN DIEGO, May 3, 2017 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for…

May 03, 2017 at 04:59PM

http://ift.tt/2pXD7ms

from

http://ift.tt/2pXD7ms